Askandal, Bb Boy .

HRN: 23-45-46  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2023
AMPICILLIN 1GM (VIAL)
08/22/2023
08/28/2023
IV
250mg
BID
Neonatal Sepsis
Waiting Final Action 
08/22/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/22/2023
08/28/2023
IV
50mg
OD
Neonatal Sepsis
Waiting Final Action 
08/25/2023
CEFTAZIDIME 1GM (VIAL)
08/25/2023
08/31/2023
IVTT
102mg
Q12
Meconium Aspiration Syndrome Versus Neonatal Pneumonia
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: